Results for tag: "Bone Marrow Transplant"

The Bone Marrow Transplant (BMT) market is a subset of the stem cell market. BMT is a medical procedure in which healthy stem cells are transplanted into a patient to replace damaged or diseased cells. The stem cells used in BMT are typically harvested from the patient's own bone marrow, or from a donor. BMT is used to treat a variety of conditions, including leukemia, lymphoma, and aplastic anemia. The BMT market is highly competitive, with a number of companies offering products and services related to the procedure. These include companies that provide stem cell collection and processing services, as well as those that manufacture and distribute BMT-related products, such as cell culture media and reagents. Additionally, there are companies that specialize in providing BMT-related services, such as patient education and support. Some of the major companies in the BMT market include StemCyte, LifeCell, and Osiris Therapeutics. Other notable companies include BioLife Solutions, Cellectis, and Thermo Fisher Scientific. Show Less Read more